Corbus Pharmaceuticals Holdings Aktie
WKN DE: A14R7P / ISIN: US21833P1030
06.08.2025 02:07:19
|
Corbus Pharma's Q2 Net Loss Widens
(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a U.S.-based pharmaceutical company, reported a wider loss in the second quarter.
The company reported a net loss of $17.7 million or $1.44 per share in the second quarter of 2025, compared to a net loss of $10 million or $0.90 per share.
The rise in losses during this quarter was caused by increased operating expenses, particularly driven by higher clinical development expenses.
Tuesday, CRBP closed at $8.90, down 4.71%, and is trading flat after hours on the NasdaqCM.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Corbus Pharmaceuticals Holdings Inc Registered Shs (Old)mehr Nachrichten
Keine Nachrichten verfügbar. |